LifeStance Health Group, Inc. Operating Expenses
LifeStance Health Group, Inc. (LFST) reported Operating Expenses of $404.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- LifeStance Health Group, Inc. operating expenses for the quarter ending 2026-06-30 was $404.70M, a 16.21% increase year-over-year.
- LifeStance Health Group, Inc. operating expenses for the quarter ending 2026-03-31 was $381.19M, a 15.04% increase year-over-year.
- LifeStance Health Group, Inc. operating expenses for the quarter ending 2025-12-31 was $364.11M, a 12.23% increase year-over-year.
- LifeStance Health Group, Inc. operating expenses for the quarter ending 2025-09-30 was $356.40M, a 13.98% increase year-over-year.
- LifeStance Health Group, Inc. operating expenses for fiscal 2025 was $1.40B, a 9.17% increase from fiscal 2024.
- LifeStance Health Group, Inc. operating expenses for fiscal 2024 was $1.28B, a 3.04% increase from fiscal 2023.
- LifeStance Health Group, Inc. operating expenses for fiscal 2023 was $1.24B, a 16.37% increase from fiscal 2022.
- LifeStance Health Group, Inc. operating expenses for fiscal 2022 was $1.07B, a 12.15% increase from fiscal 2021.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 4 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $404.70M 10-Q · filed 2026-08-06 | $785.89M 10-Q · filed 2026-08-06 | $1.15B derived: sum of 3 quarters · filed 2026-08-06 | $1.51B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $381.19M 10-Q · filed 2026-05-07 | $745.30M derived: sum of 2 quarters · filed 2026-05-07 | $1.10B derived: sum of 3 quarters · filed 2026-05-07 | $1.45B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $364.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $720.51M derived: sum of 2 quarters · filed 2026-02-25 | $1.07B derived: sum of 3 quarters · filed 2026-08-06 | $1.40B 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $356.40M 10-Q · filed 2025-11-06 | $704.66M derived: sum of 2 quarters · filed 2026-08-06 | $1.04B 10-Q · filed 2025-11-06 | $1.36B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $348.26M 10-Q · filed 2026-08-06 | $679.63M 10-Q · filed 2026-08-06 | $1.00B derived: sum of 3 quarters · filed 2026-08-06 | $1.32B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $331.37M 10-Q · filed 2026-05-07 | $655.79M derived: sum of 2 quarters · filed 2026-05-07 | $968.46M derived: sum of 3 quarters · filed 2026-05-07 | $1.30B derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $324.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $637.10M derived: sum of 2 quarters · filed 2026-02-25 | $965.37M derived: sum of 3 quarters · filed 2026-02-25 | $1.28B 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $312.68M 10-Q · filed 2025-11-06 | $640.95M derived: sum of 2 quarters · filed 2025-11-06 | $958.16M 10-Q · filed 2025-11-06 | $1.27B derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $328.28M 10-Q · filed 2025-08-07 | $645.49M 10-Q · filed 2025-08-07 | $958.36M derived: sum of 3 quarters · filed 2026-02-25 | $1.30B derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $317.21M 10-Q · filed 2025-05-07 | $630.08M derived: sum of 2 quarters · filed 2026-02-25 | $967.34M derived: sum of 3 quarters · filed 2026-02-25 | $1.28B derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $312.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $650.13M derived: sum of 2 quarters · filed 2026-02-25 | $958.12M derived: sum of 3 quarters · filed 2026-02-25 | $1.24B 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $337.25M 10-Q · filed 2024-11-07 | $645.24M derived: sum of 2 quarters · filed 2024-11-07 | $931.92M 10-Q · filed 2024-11-07 | $1.21B derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $307.99M 10-Q · filed 2024-08-08 | $594.67M 10-Q · filed 2024-08-08 | $870.04M derived: sum of 3 quarters · filed 2025-02-27 | $1.13B derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $286.68M 10-Q · filed 2024-05-09 | $562.05M derived: sum of 2 quarters · filed 2025-02-27 | $818.45M derived: sum of 3 quarters · filed 2025-02-27 | $1.09B derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $275.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $531.77M derived: sum of 2 quarters · filed 2025-02-27 | $801.77M derived: sum of 3 quarters · filed 2025-02-27 | $1.07B 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $256.40M 10-Q · filed 2023-11-08 | $526.40M derived: sum of 2 quarters · filed 2023-11-08 | $794.34M 10-Q · filed 2023-11-08 | $1.10B derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $270.00M 10-Q · filed 2023-08-09 | $537.95M 10-Q · filed 2023-08-09 | $841.70M derived: sum of 3 quarters · filed 2024-02-28 | $1.14B derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $267.95M 10-Q · filed 2023-05-10 | $571.70M derived: sum of 2 quarters · filed 2024-02-28 | $870.20M derived: sum of 3 quarters · filed 2024-02-28 | $1.08B derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $303.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $602.26M derived: sum of 2 quarters · filed 2024-02-28 | $809.85M derived: sum of 3 quarters · filed 2024-02-28 | $953.86M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $298.50M 10-Q · filed 2022-11-09 | $506.10M derived: sum of 2 quarters · filed 2022-11-09 | $650.11M 10-Q · filed 2022-11-09 | $764.28M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $207.59M 10-Q · filed 2022-08-10 | $351.61M 10-Q · filed 2022-08-10 | $465.78M derived: sum of 3 quarters · filed 2023-03-09 | $565.07M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $144.01M 10-Q · filed 2022-05-11 | $258.19M derived: sum of 2 quarters · filed 2023-03-09 | $357.48M derived: sum of 3 quarters · filed 2023-03-09 | $402.83M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $114.17M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $213.47M derived: sum of 2 quarters · filed 2023-03-09 | $258.81M 10-K · filed 2023-03-09 | |||
| 2020-09-30 | $99.29M 10-Q · filed 2021-11-10 | $144.64M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $45.35M 10-Q · filed 2021-08-12 | |||||
| 2020-05-14 | $35.49M 10-Q · filed 2021-08-12 | $102.97M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $197.28M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |